Movement Disorders and Liver Disease

被引:10
作者
Mulroy, Eoin [1 ]
Baschieri, Francesca [2 ,3 ]
Magrinelli, Francesca [1 ,4 ]
Latorre, Anna [1 ]
Cortelli, Pietro [2 ,3 ]
Bhatia, Kailash P. [1 ]
机构
[1] UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London, England
[2] IRCCS Ist Sci Neurol Bologna, Bologna, Italy
[3] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy
[4] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
关键词
liver diseases; movement disorders; ACQUIRED HEPATOCEREBRAL DEGENERATION; WILSON-DISEASE; CELIAC-DISEASE; GAUCHER-DISEASE; INBORN-ERRORS; ATAXIA-TELANGIECTASIA; CLINICAL PRESENTATION; INDUCED PARKINSONISM; BASAL GANGLIA; RISK-FACTOR;
D O I
10.1002/mdc3.13238
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The association of movement disorders with structural or functional hepatic disease occurs in three principal scenarios: (1) combined involvement of both organ systems from a single disease entity, (2) nervous system dysfunction resulting from exposure to toxic compounds in the setting of defective hepatic clearance, or (3) hepatic and/or neurological injury secondary to exposure to exogenous drugs or toxins. An important early step in the workup of any patient with combined movement disorders and liver disease is the exclusion of Wilson's disease. Diagnostic delay remains common for this treatable disorder, and this has major implications for patient outcomes. Thereafter, a structured approach integrating variables such as age of onset, tempo of progression, nature and severity of liver involvement, movement disorder phenomenology, exposure to drugs/toxins and laboratory/neuroimaging findings is key to ensuring timely diagnosis and disease-specific therapy. Herein, we provide an overview of disorders which may manifest with a combination of movement disorders and liver disease, structured under the three headings as detailed above. In each section, the most common disorders are discussed, along with important clinical pearls, suggested diagnostic workup, differential diagnoses and where appropriate, treatment considerations.
引用
收藏
页码:828 / 842
页数:15
相关论文
共 131 条
[1]   Liver involvement in Gaucher disease - Review and clinical approach [J].
Adar, Tomer ;
Ilan, Yaron ;
Elstein, Deborah ;
Zimran, Ari .
BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 :66-73
[2]   Metronidazole-induced cerebellar toxicity [J].
Agarwal, Amit ;
Kanekar, Sangam ;
Sabat, Shyam ;
Thamburaj, Krishnamurthy .
NEUROLOGY INTERNATIONAL, 2016, 8 (01) :4-6
[3]   Advances in Treatment of Wilson Disease [J].
Aggarwal, Annu ;
Bhatt, Mohit .
TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2018, 8 :1-13
[4]  
Al Sibae Mohamad Rasm, 2009, Ther Clin Risk Manag, V5, P617
[5]   Pathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation [J].
Aldridge, Dominic R. ;
Tranah, Edward J. ;
Shawcross, Debbie L. .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 :S7-S20
[6]   Characteristics of minimal hepatic encephalopathy [J].
Amodio, P ;
Montagnese, S ;
Gatta, A ;
Morgan, MY .
METABOLIC BRAIN DISEASE, 2004, 19 (3-4) :253-267
[7]   EASL Clinical Practice Guidelines: Drug-induced liver injury [J].
Andrade, Raul J. ;
Aithal, Guruprasad P. ;
Bjornsson, Einar S. ;
Kaplowitz, Neil ;
Kullak-Ublick, Gerd A. ;
Karlsen, Tom H. .
JOURNAL OF HEPATOLOGY, 2019, 70 (06) :1222-1261
[8]  
Anghel Daniela, 2013, Maedica (Bucur), V8, P170
[9]   Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease [J].
Avenali, Micol ;
Blandini, Fabio ;
Cerri, Silvia .
FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
[10]   Brain magnetic resonance imaging in non-alcoholic cirrhosis [J].
Awada, A ;
Sullivan, S ;
Palkar, V ;
Sbeih, F ;
Naufal, R ;
AlRajeh, S .
EUROPEAN JOURNAL OF RADIOLOGY, 1995, 21 (02) :84-88